IOVA Operating Cash Flow (Statement)
Iovance Biotherapeutics Inc · Operating Cash Flow (Statement)
IOVA Operating Cash Flow (Statement)
Latest reported-$264.18Mperiod ending
IOVA TTM Cash from Operations (-$57.30K → -$264.18M)
TTM operating cash flow (statement)
High-resolution chart · PNG
IOVA operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -264,182,000 | |
| -270,788,000 | |
| -302,408,000 | |
| -323,139,000 | |
| -303,410,000 | |
| -334,392,000 | |
| -352,977,000 | |
| -363,651,000 | |
| -388,761,000 | |
| -384,284,000 | |
| -361,820,000 | |
| -355,521,000 | |
| -335,087,000 | |
| -318,770,000 | |
| -292,757,000 | |
| -268,935,000 | |
| -262,979,000 | |
| -239,352,000 | |
| -227,941,000 | |
| -236,784,000 | |
| -219,606,000 | |
| -202,233,000 | |
| -205,134,000 | |
| -196,264,000 | |
| -197,931,000 | |
| -195,091,000 | |
| -158,889,000 | |
| -136,616,000 | |
| -122,362,000 | |
| -112,490,000 | |
| -101,249,000 | |
| -90,664,000 | |
| -84,182,000 | |
| -77,755,000 | |
| -78,709,000 | |
| -69,904,000 | |
| -60,667,000 | |
| -46,919,000 | |
| -32,668,000 | |
| -27,088,000 | |
| -18,722,421 | |
| -19,474,351 | |
| -18,381,000 | |
| -15,116,930 | |
| -13,002,272 | |
| -9,824,533 | |
| -8,633,247 | |
| -7,571,507 | |
| -6,269,817 | |
| -5,629,555 | |
| -3,662,192 | |
| 5,245,779 | |
| 5,392,113 | |
| 4,873,531 | |
| 4,413,314 | |
| -4,951,121 | |
| -6,319,884 | |
| -6,384,941 | |
| -6,189,199 | |
| -3,849,137 | |
| -2,312,955 | |
| -1,129,661 | |
| -620,805 | |
| -263,374 | |
| -150,590 | |
| -68,730 | |
| -14,448 | |
| -16,134 | |
| -16,586 | |
| -30,682 | |
| -57,303 |